Vorasidenib in IDH1- or IDH2-mutant low-grade glioma Journal Article


Authors: Mellinghoff, I. K.; van den Bent, M. J.; Blumenthal, D. T.; Touat, M.; Peters, K. B.; Clarke, J.; Mendez, J.; Yust-Katz, S.; Welsh, L.; Mason, W. P.; Ducray, F.; Umemura, Y.; Nabors, B.; Holdhoff, M.; Hottinger, A. F.; Arakawa, Y.; Sepulveda, J. M.; Wick, W.; Soffietti, R.; Perry, J. R.; Giglio, P.; de la Fuente, M.; Maher, E. A.; Schoenfeld, S.; Zhao, D.; Pandya, S. S.; Steelman, L.; Hassan, I.; Wen, P. Y.; Cloughsey, T. F.
Article Title: Vorasidenib in IDH1- or IDH2-mutant low-grade glioma
Journal Title: New England Journal of Medicine
Volume: 389
Issue: 7
ISSN: 0028-4793
Publisher: Massachusetts Medical Society  
Date Published: 2023-08-17
Start Page: 589
End Page: 601
Language: English
DOI: 10.1056/NEJMoa2304194
PROVIDER: EBSCOhost
PROVIDER: cinahl
PUBMED: 37272516
PMCID: PMC11445763
DOI/URL:
Notes: Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors